Shifting Treatment Paradigms in Non-Hodgkin Lymphomas
Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or progression following standard immunochemotherapy (ICT). The introduction of novel targeted immunotherapy agents has potentially ushered in a new era...
Main Authors: | Dolores Caballero, Umberto Vitolo, Martin Dreyling, Roch Houot |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-08-01
|
Series: | European Medical Journal Hematology |
Subjects: | |
Online Access: | https://www.emjreviews.com/hematology/symposium/shifting-treatment-paradigms-in-non-hodgkin-lymphomas/ |
Similar Items
-
NON-HODGKIN'S LYMPHOMA
by: Sajjad Ahmad Baloch
Published: (2015-01-01) -
ORAL AND MAXILLOFACIAL NON-HODGKIN’S LYMPHOMAS
by: Andrei Nicolau, et al.
Published: (2018-07-01) -
Non-Hodgkin's lymphoma: A review
by: Rohit Singh, et al.
Published: (2020-01-01) -
Surgery for non-Hodgkin’s lymphoma
by: Elroy Patrick Weledji, et al.
Published: (2015-07-01) -
Rare Case of Non-Hodgkin’s Lymphoma of the Thyroid
by: Srirama Bhat, et al.
Published: (2020-05-01)